Skip to content

Bio-Techne Corp Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 18, 2026 results vs estimates

Bio-Techne Corp · E.TECH.NASDAQ · United States
Use symbol E.TECH.NASDAQ in our API & Excel add-in to retrieve this data ↓
72.71
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 1.92%

Bio-Techne Corp Forecast

Bio-Techne Corp short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 1.9% a year, a typical one-standard-deviation range is 72.51–72.91 over a week, 72.31–73.11 over a month and 71.32–74.10 over a year. (Signals as of 1 Nov 2026.)

Bio-Techne Corp Price Chart

MacroFinance.ai

Bio-Techne Corp Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Bio-Techne Corp
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Bio-Techne Corp
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Bio-Techne Corp
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Bio-Techne Corp
P/E
66.77x
Mid-range vs own history
QoQ −35.5%
YoY −45.9%
now 66.77362.02 low137.69 high
ⓘP/E As of 22 Nov 2026.See Bio-Techne Corp returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Bio-Techne Corp
P/S
9.35x
Mid-range vs own history
QoQ −0.3%
YoY +18.2%
now 9.34945.61 low9.39 high
ⓘP/S As of 22 Nov 2026.See Bio-Techne Corp returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Bio-Techne Corp
P/B
5.30x
Mid-range vs own history
QoQ −2.6%
YoY +8.3%
now 5.30223.26 low5.46 high
ⓘP/B As of 22 Nov 2026.See Bio-Techne Corp returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Bio-Techne Corp
EV/EBITDA
34.73x
Mid-range vs own history
QoQ −21.6%
YoY −22.0%
now 34.727726.65 low49.57 high
ⓘEV/EBITDA As of 22 Nov 2026.See Bio-Techne Corp returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Bio-Techne Corp
EV/Sales
9.30x
Mid-range vs own history
QoQ −1.5%
YoY +14.6%
now 9.29615.68 low9.45 high
ⓘEV/Sales As of 22 Nov 2026.See Bio-Techne Corp returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Bio-Techne Corp
FCF Yield
2.7%
Strong vs own history
QoQ +13.0%
YoY +15.3%
now 2.6842.09 low3.97 high
ⓘFCF Yield As of 22 Nov 2026.See Bio-Techne Corp returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Bio-Techne Corp
Earnings Yield
1.5%
Mid-range vs own history
QoQ +55.1%
YoY +84.8%
now 1.49760.73 low1.61 high
ⓘEarnings Yield As of 22 Nov 2026.See Bio-Techne Corp returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Bio-Techne Corp
Dividend Yield
0.4%
Mid-range vs own history
QoQ −0.7%
YoY −16.4%
now 0.43570.44 low0.73 high
ⓘDividend Yield As of 22 Nov 2026.See Bio-Techne Corp returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Bio-Techne Corp
Market Cap
$11.5B
Mid-range vs own history
QoQ +1.2%
YoY +19.4%
now 11482.94496,796 low11,497 high
ⓘMarket Cap As of 22 Nov 2026.See Bio-Techne Corp returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Bio-Techne Corp
Net Debt
-$66M
Low vs own history
QoQ −181.5%
YoY −126.3%
now -65.573-65.57 low249.51 high
ⓘNet Debt As of 22 Nov 2026.See Bio-Techne Corp returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Bio-Techne Corp
Net Debt / EBITDA
-0.20x
Low vs own history
QoQ −163.9%
YoY −117.7%
now -0.1995-0.2 low1.13 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Bio-Techne Corp returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Bio-Techne Corp
Current Ratio
2.28x
Weak vs own history
QoQ −49.1%
YoY −45.9%
now 2.28312.28 low4.55 high
ⓘCurrent Ratio As of 22 Nov 2026.See Bio-Techne Corp returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Bio-Techne Corp
Quick Ratio
1.74x
Weak vs own history
QoQ −45.3%
YoY −38.2%
now 1.7361.74 low3.35 high
ⓘQuick Ratio As of 22 Nov 2026.See Bio-Techne Corp returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Bio-Techne Corp
Interest Coverage
22.13x
Mid-range vs own history
QoQ +47.5%
YoY +77.5%
now 22.12912.47 low22.13 high
ⓘInterest Coverage As of 22 Nov 2026.See Bio-Techne Corp returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Bio-Techne Corp
Debt / Equity
0.13x
Low vs own history
QoQ −5.3%
YoY −34.3%
now 0.13190.13 low0.2 high
ⓘDebt / Equity As of 22 Nov 2026.See Bio-Techne Corp returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Bio-Techne Corp
Piotroski F-Score
7
Mid-range vs own history
QoQ 0.0%
YoY +40.0%
now 75 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Bio-Techne Corp returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Bio-Techne Corp
Altman Z-Score
16.2
Mid-range vs own history
QoQ +0.1%
YoY +37.8%
now 16.20310.32 low16.22 high
ⓘAltman Z-Score As of 22 Nov 2026.See Bio-Techne Corp returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Bio-Techne Corp, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Bio-Techne Corp fundamentals: income statement, balance sheet & cash flow

Bio-Techne Corp reported revenue of $1.22bn and net income of $181.9m in FY2026, the year ended 30 June 2026 — revenue down 0.4% and net income up 147.8% on the prior year. Free cash flow was $263.2m. These figures are as reported in the filings, not restated: 38 fiscal years and 149 quarters of history, back to June 1989. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2026)
$1.22bn
-0.4%
Net income
$181.9m
+147.8%
Gross margin
65.77%
Free cash flow
$263.2m
+2.6%
Net debt
$24.4m
Shares short (30 Oct 2026)
7.70m
2.73 days to cover
Bio-Techne Corp income statement, annual, as reported · USD millions unless stated
USD millionsFY2026FY2025FY2024FY2023FY2022
Period end30 Jun 202630 Jun 202530 Jun 202430 Jun 202330 Jun 2022
Revenue1,215.01,219.61,159.11,136.71,105.6
Cost of revenue416.0429.4389.3366.9349.1
Gross profit799.1790.3769.7769.8756.5
Research & development94.899.596.792.587.1
Selling, general & admin.452.4————
Operating income251.9102.3206.7298.9296.6
EBITDA343.4216.9313.1457.1413.8
Interest expense5.48.515.711.211.3
Pre-tax income240.798.5185.7338.7301.4
Income tax58.825.117.653.238.3
Net income181.973.4168.1285.3272.1

Download Bio-Techne Corp fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.TECH.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 38 fiscal years and 149 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Bio-Techne Corp

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Bio-Techne Corp Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Bio-Techne Corp; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Bio-Techne Corp’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Bio-Techne Corp behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Bio-Techne Corp (United States)

Bio-Techne Corp is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Bio-Techne Corp

Frequently asked questions

What is Bio-Techne Corp?
Bio-Techne Corp is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Bio-Techne Corp price?
The latest close is 72.71 (1 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Bio-Techne Corp in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Bio-Techne Corp?
20-day realised volatility is 1.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 0.6% over a month and 0.3% over a week.
What factors affect Bio-Techne Corp?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Bio-Techne Corp, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Bio-Techne Corp?
58 backtested tactical asset allocation strategies trade Bio-Techne Corp through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Bio-Techne Corp returns analysed?
The Statistical Distribution of Returns section shows the distribution of Bio-Techne Corp daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Bio-Techne Corp historical data?
In the Free historical data section of this page: the last 10 years of Bio-Techne Corp daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Bio-Techne Corp historical data (last 10 years)

Browse or instantly download the last 10 years of Bio-Techne Corp daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.TECH.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2072.67
2026-11-1972.7
2026-11-1872.75
2026-11-1772.63
2026-11-1672.79
2026-11-1372.8
2026-11-1272.76
2026-11-1172.72
2026-11-1072.74
2026-11-0972.75
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.